A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: A gynecologic oncology group study
Authors:
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 125 (1) , 158-162
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2009
- A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancerGynecologic Oncology, 2009
- A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: A gynecologic oncology group studyGynecologic Oncology, 2009
- A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group studyGynecologic Oncology, 2007
- Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: A phase I/II study of the Gynecologic Oncology GroupGynecologic Oncology, 2006
- Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A phase I trial of the Puget Sound Oncology ConsortiumGynecologic Oncology, 2006
- Randomized Comparison of Weekly Cisplatin or Protracted Venous Infusion of Fluorouracil in Combination With Pelvic Radiation in Advanced Cervix Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2005
- Phase II Trial of Topotecan and Cisplatin in Persistent or Recurrent Squamous and Nonsquamous Carcinomas of the CervixGynecologic Oncology, 2002
- A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer PatientsGynecologic Oncology, 2001
- Cytotoxic Effects of Topotecan Combined With Various Anticancer Agents in Human Cancer Cell LinesJNCI: Journal of the National Cancer Institute, 1996